Abstract:Background Cardiac sarcoidosis (CS) can present with various symptoms including heart failure, arrhythmias or sudden cardiac death. Due to this diverse presentation, the management can be challenging. We present a case of CS illuminating the significance of multimodality imaging techniques. Case 26-year male with biopsy proven pulmonary sarcoidosis presented with palpitation and lightheadedness. EKG showed ventricular tachycardia (VT). Left Heart Catheterization showed nonobstructive coronaries. Cardiac MRI (CMR) with Delayed Hyper-Enhancement (DHE) images showed areas of fibrosis mostly in the septum and active inflammation mostly in the inferolateral and anterolateral wall consistent with CS. ICD was placed to prevent VT. Subsequently, Positron Emission Tomography (PET) scan was performed that showed significant diffuse uptake of the radiotracer in the left ventricular myocardium which demonstrated active CS. Patient was initially started on methotrexate and treatment was later escalated to infliximab with improvement of symptoms. Discussion Approximately 5% of patients with sarcoidosis experience CS. The clinical features, laboratory biomarkers, and traditional imaging findings have their limitations. The 2014 Heart Rhythm Society (HRS) Expert Consensus guideline includes both PET scan and CMR to increase diagnostic yield. CMR uses Late Gadolinium Enhancement (LGE) to assess function and identify fibrosis, while 18F-FDG PET scan uses 18F-FDG to assess myocardial inflammation. A study by Vita et.al showed that one third of LGE positive patients had no FDG uptake on PET scan. This concluded that CMR and PET provide complementary value in guiding further management as they assess different pathophysiology of the disease as evident in our case. Thus, our patient received a combination of ICD placement for scarring and anti-inflammatory agent for active inflammation. The amount of myocardial late enhancement detected during CMR is correlated with impaired left ventricular function and has prognostic implications. Blankstein et al. concluded that abnormal FDG uptake and perfusion defects are associated with higher risk of VT and death. Conclusion Randomized control trials are needed to standardize CS diagnostic criteria with PET and CMR, preventing under-diagnosis and guiding further management.

Cancer cell migration in 3D tissue: Negotiating space by proteolysis and nuclear deformability

Pericardial Synovial Sarcoma in a Dyspnoeic Female with Tuberculous Pericarditis: A Case Report.

18F-FDG PET/CT Imaging in Primary Cardiac Angiosarcoma

F-18-FDG PET/CT Imaging in Primary Cardiac Angiosarcoma Diagnosis and Follow-Up

A case report of primary pericardial sarcoma

Recurrent Pericardial Effusions and Intrapericardial Thrombi of Unknown Etiology

Rare Cardiac Tumor: Do We Know All About Cardiac Myxofibrosarcoma?

18 F-FAPI PET/CT Imaging in a Case of Synovial Sarcoma

18F-FAPI PET/CT Imaging in a Case of Synovial Sarcoma

Multimodal imaging features of primary pericardial synovial sarcoma: a case report

A unique presentation of pericardial epithelioid angiosarcoma with multifaceted complications

Case Report: Thromboembolism and Hemorrhagic Pericardial Effusion—The Janus Face of Primary Pericardial Angiosarcoma

Application of 18F-Fdg Pet/Ct in Diagnosis and Management of Pericardial Effusion

Imaging Features Differentiating Between Cardiac Sarcomas and Hematologic Neoplasms

Primary cardiac lymphoma: a case report

Primary pericardial angiosarcoma with pleural metastasis: an unusual clinical presentation

Role of 18 F-FDG PET/CT imaging in cardiac and pericardial masses

Recurrence of an undifferentiated pleomorphic pulmonary artery sarcoma 8 years after initial presentation: a case report

18F-FDG PET/CT Imaging Findings of a Case of Primary Cardiac Chondrosarcoma and Pulmonary Inflammation

Intense 68Ga-OncoFAP Uptake as a New Promising Diagnostic Biomarker in Cardiac Sarcoidosis

Revealing The Enigma Of Cardiac Sarcoidosis: The Crucial Significance Of Advanced Imaging Modalities- A Case Report